VDR and chronic kidney disease: It is possible that the differences observed in gene and protein expression of vitamin D regulatory pathway components in CKD arteries is driven by osteogenic transformation, with osteocyte-like VSMC unable to respond to vitamin D receptor agonists in the same way as healthy VSMCs.